Hypertension and the prothrombotic state

Journal of Human Hypertension

Volumn 14, Issue 10-11, 2000, Pages 687-690

  Lip, G Y H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

Coagulation; Haemorheology; Hypercoagulable; Prognosis; Prothrombotic

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BLOOD CLOTTING FACTOR; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; CYTOKINE; DIURETIC AGENT; FIBRINOGEN; GLUCOCORTICOID; INTERLEUKIN 1; PROTHROMBIN; THIAZIDE DIURETIC AGENT; TUMOR NECROSIS FACTOR; VON WILLEBRAND FACTOR;

BLOOD RHEOLOGY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG EFFECT; ENDOTHELIUM INJURY; FIBRINOGEN BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEART RIGHT VENTRICLE HYPERTROPHY; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; HYPERTENSION; PROGNOSIS; REVIEW; STROKE; THROMBOEMBOLISM;

EID: 0033755029     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001051     Document Type: Review

References (42)

1. Blood pressure, stroke and coronary heart disease
2. Guidelines for management of hypertension: Report of the third working party of the British Hypertension Society 1999
3. Phlogose und Thrombose in Gerasystem
4. Does hypertension confer a prothrombotic state? Virchow's triad revisited
5. Abnormalities of rheology and coagulation in hypertension
6. The role of rheology and haemostatic factor in hypertension
7. Haemostasis in normotensive and hypertensive men - Results of the PROCAM Study
8. Association between blood pressure and fibrinolytic potential in the Framingham Offspring population
9. The relationship between blood viscosity and blood pressure in a random sample of the population aged 55 to 74 years
10. Relationship of endothelium, thrombogenesis, and haemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy
11. Prothrombotic factors, endothelial function and left ventricular hypertrophy in isolated systolic hypertension compared with systolic-diastolic hypertension
12. Prothrombin fragment 1+2 is a risk factor for myocardial infarction in treated hypertensive men
13. Abnormal baseline endothelial dysfunction and thrombogenesis are related to prognosis in hypertension
14. ECAT angina pectoris study: Baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography
15. Plasma fibrinogen - A major coronary risk factor
16. Association of left ventricular hypertrophy and chronic atrial fibrillation with the incidence of new thromboembolic stroke in 2384 older persons
17. Microalbuminuria and endothelial dysfunction inessential hypertension
18. Von Willebrand factor and endothelial damage in essential hypertension
19. The endothelium: Target or promoter of hypertension?
20. Epidemiological features of chronic atrial fibrillation. The Framingham Study
21. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation
22. Does atrial fibrillation confer a hypercoagulable state?
23. Epidemiology of heart failure
24. Does heart failure confer a hypercoagulable state? Virchow's triad revisited
25. Ventricular dysfunction and the risk of stroke after myocardial infarction
26. Von Willebrand factor and soluble E-selectin in hypertension: Influence of treatment and value in predicting the progression of atherosclerosis
27. Effects of felodipine ER and hydrochlorothiazide on blood rheology in essential hypertension - A randomised, double-blind, cross-over study
28. Effects of lisinopril and hydrochlorothaizide on platelet function and blood rheology in essential hypertension: A randomly allocated double-blind study
29. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension
30. Medical Research Council trial of treatment of hypertension in older adults: Principal results
31. Baseline rest electrocardiographic abnormalities, antihypertensive treatment, and mortality in the Multiple Risk Factor Intervention Trial
32. Systolic versus diastolic blood pressure and risk of coronary heart disease
33. Systolic and diastolic blood pressure as predictors of coronary heart disease in the Whitehall Study
34. Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease
35. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension (SYST-EUR Trial)
36. Abandoning diastole
37. Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease
38. Haematological stress syndrome in atherosclerosis
39. Fibrinogen and cardiovascular disease
40. The endothelium in atherothrombotic disease: Assessment of function, mechanisms and clinical implications
41. Vessel wall interactions regulating thrombosis
42. Cytokine mediated activation of vascular endothelium